Albemarle Co. (NYSE:ALB – Get Free Report) has received an average recommendation of “Hold” from the twenty-one brokerages that are presently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, fourteen have issued a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $91.62.
A number of analysts recently weighed in on the stock. Piper Sandler set a $68.00 target price on shares of Albemarle and gave the stock an “underweight” rating in a research note on Wednesday, May 14th. BMO Capital Markets lowered their target price on shares of Albemarle from $150.00 to $140.00 in a research report on Wednesday, February 12th. KeyCorp decreased their price target on Albemarle from $102.00 to $95.00 and set an “overweight” rating for the company in a report on Friday, May 2nd. TD Securities reduced their target price on Albemarle from $115.00 to $65.00 and set a “hold” rating for the company in a report on Thursday, May 1st. Finally, JPMorgan Chase & Co. reduced their target price on Albemarle from $80.00 to $60.00 and set a “neutral” rating for the company in a report on Tuesday, May 6th.
Check Out Our Latest Research Report on ALB
Hedge Funds Weigh In On Albemarle
Albemarle Stock Performance
ALB opened at $57.64 on Friday. Albemarle has a 12-month low of $49.43 and a 12-month high of $129.50. The company has a current ratio of 1.95, a quick ratio of 1.19 and a debt-to-equity ratio of 0.39. The firm has a market capitalization of $6.78 billion, a PE ratio of -5.15 and a beta of 1.71. The firm has a 50 day moving average of $61.45 and a two-hundred day moving average of $80.41.
Albemarle (NYSE:ALB – Get Free Report) last announced its earnings results on Wednesday, April 30th. The specialty chemicals company reported ($0.18) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.62) by $0.44. The company had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.18 billion. Albemarle had a negative net margin of 21.93% and a negative return on equity of 1.72%. The firm’s quarterly revenue was down 20.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.26 EPS. On average, analysts anticipate that Albemarle will post -0.04 EPS for the current year.
Albemarle Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Friday, June 13th will be paid a $0.405 dividend. The ex-dividend date of this dividend is Friday, June 13th. This represents a $1.62 annualized dividend and a yield of 2.81%. Albemarle’s payout ratio is -14.57%.
About Albemarle
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Further Reading
- Five stocks we like better than Albemarle
- Learn Technical Analysis Skills to Master the Stock Market
- Pfizer’s 7.5% Dividend: Income Haven or House of Cards?
- What is a support level?
- 3 Trades Members of Congress Are Making Right Now
- How to Calculate Retirement Income: MarketBeat’s Calculator
- TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.